News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OTLK market cap is 119.69M. The company's latest EPS is USD -0.2538 and P/E is -1.69.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.04M | -14M | -15.67M | -6.86M | -18.15M |
| Net Income | -17.54M | -14.35M | -18.66M | -6.65M | -20.68M |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.09M | 8.15M | 0 | 0 | 0 |
| Operating Income | -29.64M | -36.3M | -36.84M | -51.77M | -63.12M |
| Net Income | -48.02M | -36.04M | -48.87M | -53.16M | -66.05M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 38.59M | 28.53M | 62.69M | 54.02M | 44.45M |
| Total Liabilities | 18.51M | 19.79M | 46.93M | 43.54M | 49.95M |
| Total Equity | 20.08M | 8.74M | 15.76M | 10.49M | -5.5M |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 22.28M | 17.14M | 19.73M | 22.81M | 28.53M |
| Total Liabilities | 43.09M | 27.91M | 16.91M | 18.2M | 19.79M |
| Total Equity | -25.55M | -16.13M | 2.83M | 4.61M | 8.74M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -46.42M | -56.67M | -8.9M | -17.02M | -30.23M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 57.97M | 59.59M | 43.85M | 43.25M | 46.54M |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -33.04M | -32.29M | -31.79M | -54.25M | -56.67M |
| Investing | -2.78M | -437k | -900k | N/A | N/A |
| Financing | 34.35M | 39.03M | 37.21M | 56.19M | 59.59M |
| Market Cap | 119.69M |
| Price to Earnings Ratio | -1.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.44 |
| Price to Book Ratio | 12.81 |
| Dividend Yield | - |
| Shares Outstanding | 260.25M |
| Average Volume (1 week) | 1.73M |
| Average Volume (1 Month) | 2.61M |
| 52 Week Change | -57.02% |
| 52 Week High | 2.03 |
| 52 Week Low | 0.2002 |
| Spread (Intraday) | 0.05 (10.87%) |
| Company Name | Outlook Therapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.outlooktherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
